"The hardest years of my life," is how Cambridge scientist David Sabatini describes the time since his downfall from MIT.

Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the ...

White House planned shift of research funding from universities to industry risks creating a drought in basic research, ...

The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared ...

Was molecular biologist David Sabatini a manipulative mentor who coerced a younger colleague into sex? Or was he the victim ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

As I prepared for my appointment, the hospital asked me to sign its registration forms and to sign up for MyChart. In the ...

Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news ...

Working conditions are the larger problem. Burnout, chronic understaffing, and high turnover are among the most consistent ...

At the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.

Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry.

In mental health care, I encountered people who believed that medication changed who they were. They didn’t mean the common ...